Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children

Pediatric Critical Care Medicine

Volumn 7, Issue 2, 2006, Pages 115-118

  Ben Ari, Josef ^a   Samra, Zmira ^b   Nahum, Elhanan ^a   Levy, Izhak ^a   Ashkenazi, Shai ^c   Schonfeld, Tommy M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

Amphotericin B; Candida; Candidemia; Nosocomial; Pediatric intensive care unit; Preventive

Indexed keywords

AMPHOTERICIN B;

ANTIBIOTIC PROPHYLAXIS; ARTIFICIAL VENTILATION; CANDIDA; CANDIDIASIS; CHILD; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFICACY; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SUSPENSION; TREATMENT OUTCOME; WEANING;

EID: 33645536699     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000200946.30263.B6     Document Type: Article

References (21)

1. Sobel JD, Rex JH: Invasive candidiasis: Turning risk into practical prevention policy? Clin Infect Dis 2001; 33:187-189
2. Singhi SC, Reddy TCS, Chakrabarti A: Candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2004; 5:369-374
3. Gray J, Gossian S, Morris K: Three-year survey of bacteremia and fungemia in a pediatric intensive care unit. Pediatr Infect Dis J 2001; 20:416-421
4. Urrea M, Pons M, Serra M, et al: Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr Infect Dis J 2003; 22:490-494
5. Hiranandani M, Singhi SC, Kauri I, et al: Disseminated nosocomial candidiasis in a pediatric intensive care unit. Indian Pediatr 1995; 32:1160-1166
6. Blumberg HM, Jarvis WR, Soucie M, et al: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. Clin Infect Dis 2001; 33:177-186
7. Rex JH, Sobel JD: Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001; 32:1191-1200
8. Wisplinghoff H, Seifert H, Tallent, et al: Nosocomial bloodstream infections in pediatric patients in United States hospitals: Epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003; 22:686-691
9. Tortorano M, Biraghi E, Astolfi A, et al: European Confederation of Medical Mycology (ECMM) Prospective Survey of Candidaemia: Report from one Italian region. J Hosp Infect 2002; 51:297-304
10. Wenzel PR: Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis 1995; 20:1531-1534
11. MacDonald L, Backer C, Chenoweth C: Risk factors for candidemia in children's hospital. Clin Infect Dis 1998; 26:642-645
12. Krause W, Matheis H, Wulf K: Fungemia and funguria after oral administration of Candida albicans. Lancet 1969; 1:598-599
13. Bendel CM: Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis. Semin Perinatol 2003; 27:357-364
14. Kicklighter SD, Springer SC, Cox T, et al: Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001; 107:293-298
15. Kaufman D, Boyle R, Hazen KC, et al: Fluconazole for prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001; 345:1660-1666
16. Denning DW, Donnelly JP, Hellreigel KP, et al: Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: What is the state of the art? Ad Hoc Working Group. Chemotherapy 1992; 38(Suppl 1):43-49
17. Menichetti F, Del-Favero A, Martino P, et al: Preventing fungal infection in neutropenic patients with acute leukemia: Fluconazole compared with oral amphotericin B. The GIMEMA Infection Program. Ann Intern Med 1994; 120:913-918
18. De Laurenzi A, Matteocci A, Lanti A, et al: Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: A single center experience from 1980 to 1995. Infection 1996; 24:361-366
19. Nolla-Sala SJ, Stiges-Srra A, Loan-Gil C, et al: Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy. Study group of fungal infection in ICU. Intensive Care Med 1997; 23:23-30
20. Rowen JL, Rench MA, Kozinetz LA, et al: Endotracheal colonization with Candida enhances the risk of systemic candidiasis in very low birth weight infants. J Pediatr 1994; 124:789-794
21. Cole GT, Halawa AA, Anaissie EJ: The role of the gastrointestinal tract in hematogenous candidiasis: From the laboratory to the bedside. Clin Infect Dis 1996; 22(Suppl 2):S73-S88